Monthly Distribution of Wild Poliovirus Cases1,

Slides:

Advertisements

Similar presentations

WHO Regional Office for Europe Vaccine preventable diseases and Immunization programme Diphtheria Incidence in the WHO European Region 1990 Source; WHO/UNICEF.

Advertisements

1 |1 | Countries using and planning to introduce IPV July 2014 status report This slide deck provides a summary per country on the status of planning for.

1 |1 | Countries using and planning to introduce IPV.

Monitoring progress towards the coverage and disease incidence targets GLOBAL MEASLES AND RUBELLA MANAGEMENT MEETING March 2011 Geneva, Switzerland.

1 |1 | Countries using and planning to introduce IPV.

1 |1 | Countries using and planning to introduce IPV.

Vaccine in National Immunization Programme Update March 2015.

1 |1 | Countries using and planning to introduce IPV.

1 |1 | Countries using and planning to introduce IPV.

World Health Organization

1 |1 | Countries using and planning to introduce IPV.

TITLE from VIEW and SLIDE MASTER | August 7, |1 | Countries with Hib vaccine in the national immunization programme; and planned introductions *

WHO Regional Office for Europe Vaccine preventable diseases and Immunization programme Measles containing vaccine (MCV1) coverage in the WHO European Region.

World Health Organization

Polio Update Pre Tender Meeting 11 th December 2008 UNICEF Supply Division.

1 |1 | Countries using and planning to introduce IPV.

Highlights of New WPV Cases 34 new cases in 5 countries 14 cases (14 W3) but no new district in India Most recent date of onset 03 Oct 1 case (W1) but.

Data in WHO HQ as of 09 October 2012 Highlights of New Wild Poliovirus Cases The boundaries and names shown and the designations used in the maps in this.

NVAC W. R. Dowdle. Laboratory Containment of Wild Poliovirus in the United States Phase I National Survey and Inventory Final Report January.

1 |1 | Countries using and planning to introduce IPV.

1 |1 | Countries using and planning to introduce IPV and the global status of bOPV registration Countries using and planning to introduce IPV and the global.

Data in WHO HQ as of 17 Apr 2012 Highlights of New Wild Poliovirus Cases The boundaries and names shown and the designations used in the maps in this document.

WHO and International Panel International Collaborative Effort on Injury Statistics Hyatt Regency, Washington September 7-8, 2006.

Global Programme on Evidence for Health Policy The use of GIS in the Global Programme on Evidence for Health Policy (GPE) Meeting on Cartography and Geographic.

Vaccine in National Immunization Programme Update April 2016.

World Health Organization

Data quality for polio eradication: Accuracy & reliability

SAGE 2010 Sampling Distribution

2016 Immunization Coverage Data at Subnational Level

Measles disease An acute viral infection spread via respiratory secretions or aerosols Classic manifestations: Maculopapular rash Fever +cough + coryza/conjuctivities.

reporting rate of discarded cases* per 100'000 population**

Ageing Matters Somnath Chatterji Information, Evidence and Research

World Health Organization

PROGRESS IN GLOBAL TB CONTROL

World Health Organization

SAGE 2009 Sampling Distribution

World Health Organization

06/12/2018 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.

Countries Having Introduced Hib Vaccine

Countries Having Introduced Hib Vaccine and Infant Hib Coverage, 2010

Circulating Vaccine-derived Poliovirus*, last 6 months

Sampling Distribution

15/01/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week The boundaries and names shown and the designations used in.

Non-polio AFP Rate July 2014 – June 2015 July 2015 – June 2016

Monthly Distribution of Wild Poliovirus Cases1,

(70 countries or 36%) (23 countries or 12%)

Countries with Genotype data available

Countries Using Hib Vaccine in National Immunization Schedule in 2010 and Countries Approved for GAVI Support for Use from 2011 Onwards Yes (166 countries.

World Health Organization

24/02/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.

World Health Organization

Onset of most recent WPV1 Case Number of WPV infected districts

08/04/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.

Countries having introduced HepB vaccine

No new positives this week

05/04/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.

Most-affected regions in the Russian Federation

08/04/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week The boundaries and names shown and the designations used in.

Mapping Levels of Palliative Care Development: A Global Update

Countries Using Mening Vaccine in National Immunization Schedule 2011

- Use same categories as for bar chart below Introduced Without GAVI

Onset of most recent case Number of infected districts

04/05/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1contacts of positive AFP cases, community, healthy children.

Meningitis/Encephalitis Surveillance Countries reporting to WHO Network or with Other (non-WHO Network) Surveillance Activities WHO Network (46 member.

16/05/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.

27/08/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.

2,100 4,200 1,050 Kilometers < 90% (75 countries or 39%)

World Health Organization

Attachment B-3: Animation of 137Cs deposition on ground/sea surface

World Health Organization

Presentation transcript:

Monthly Distribution of Wild Poliovirus Cases1, 2013-20172 WPV type 1 Number of Wild Poliovirus Cases 2013 2014 2017 2016 2015 1By date of onset of paralysis. Cases with onset in January 2018 will be reflected in the next update. 2No WPV2 nor WPV3 cases were reported in 2013 - 2017. Data in WHO HQ as of 13 February 2018

Ambiguous Vaccine-derived Poliovirus (aVDPV)1 Cases, 2008-2017 1For aVDPV definition see : http://polioeradication.org/wp-content/uploads/2016/09/Reporting-and-Classification-of-VDPVs_Aug2016_EN.pdf Figure includes only aVDPV positives from AFP case reporting. Data in WHO HQ as of 13 February 2018

Non-polio AFP Rate January 2016 – December 2016 < 0.5 0.5 - 0.99 > 1 No AFP Surveillance/data The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO 2017. All rights reserved Data in WHO HQ as of 13 February 2018

Adequate Stool Collection Percentage January 2016 – December 2016 January 2017 – December 2017 < 60% 60% - 79.99% > 80% No AFP Surveillance/data The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO 2017. All rights reserved Data in WHO HQ as of 13 February 2018

Surveillance Indicators, AFRO and EMRO January 2017 – December 2017 (Rolling 12 months) Non-polio AFP rate < 1 1 – 1.99 >= 2 Adequate stool collection percentage < 50% 50 – 79.99% >= 80% The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO 2017. All rights reserved Data in WHO HQ as of 13 February 2018

Surveillance Indicators, AFRO and EMRO July 2017 – December 2017 (Rolling 6 months) Non-polio AFP rate < 1 1 – 1.99 >= 2 Adequate stool collection percentage < 50% 50 – 79.99% >= 80% The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO 2017 All rights reserved Data in WHO HQ as of 13 February 2018